This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that have much the same symptoms: COVID-19, flu and RSV. And many more ...
Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...
Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the pandemic All tests now work seamlessly with navify® ...
U.S. consumers may already be familiar with Roche’s rapid antigen test for COVID-19. The mass-produced, at-home screener was distributed to tens of millions of people through the mail this year via ...
INDIANAPOLIS — If you signed up to get free rapid at-home COVID-19 tests kits from the federal government, you should see them in your mailbox in the next seven to 12 days. You can't choose the brand ...
As the COVID-19 pandemic continues into the fall, Roche Group is planning to launch its latest tool later this month. And while its SARS-CoV-2 Rapid Antigen Test will be available in markets accepting ...
The U.S. Department of Defense has awarded a $340 million contract to Roche Diagnostics in Indianapolis that calls for the production of COVID-19 rapid antigen tests for the U.S. government. Work will ...
Roche (OTCQX:RHHBY) (OTCQX:RHHBF) is actively working with its partners to enhance laboratory testing capacity worldwide to combat the mpox outbreak. Mpox is a viral infection that causes flu-like ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback